2014
DOI: 10.3233/jad-131916
|View full text |Cite
|
Sign up to set email alerts
|

Initial Memory Deficit Profiles in Patients with a Cerebrospinal Fluid Alzheimer's Disease Signature

Abstract: In a population initially presenting with memory complaints and depicting a CSF AD signature, a high proportion of medial temporal amnesia is disclosed as expected, but also a proportion of dysexecutive amnesia and normal FCSRT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 39 publications
0
13
0
Order By: Relevance
“…In this context, tests assessing episodiclike memory, thought to assess the function of the hippocampus complex, have been increasingly used as an early marker of AD and amnesia was eventually considered as the core clinical feature of typical AD. This overlap between amnesia, AD and hippocampal dysfunctions led some authors to hypothesize the existence of an "amnestic syndrome of hippocampal type" (Dubois et al, 2004;Sarazin et al, 2007;Xie et al, 2014) or in other words, a cognitive syndrome characterized by memory storage difficulties due to hippocampal atrophy, that would be specific to AD. Cued memory paradigms and the FCSRT in particular, were then subsequently used to track the conversion from MCI to AD (Sarazin et al, 2007), as well as for the positive (Dubois et al, 2004(Dubois et al, , 2014Xie et al, 2014) and differential diagnosis of AD (Pasquier et al, 2001;Teichmann et al, 2017;Lemos et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…In this context, tests assessing episodiclike memory, thought to assess the function of the hippocampus complex, have been increasingly used as an early marker of AD and amnesia was eventually considered as the core clinical feature of typical AD. This overlap between amnesia, AD and hippocampal dysfunctions led some authors to hypothesize the existence of an "amnestic syndrome of hippocampal type" (Dubois et al, 2004;Sarazin et al, 2007;Xie et al, 2014) or in other words, a cognitive syndrome characterized by memory storage difficulties due to hippocampal atrophy, that would be specific to AD. Cued memory paradigms and the FCSRT in particular, were then subsequently used to track the conversion from MCI to AD (Sarazin et al, 2007), as well as for the positive (Dubois et al, 2004(Dubois et al, , 2014Xie et al, 2014) and differential diagnosis of AD (Pasquier et al, 2001;Teichmann et al, 2017;Lemos et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…pFCSRT 1 IR performance detects amnestic MCI and dementia, predicts future dementia and AD, and distinguishes AD dementias from non-AD dementias [30][31][32][33][34][35][36]. Accumulating data demonstrating its association with the CSF AD signature [37,38], structural and functional imaging [39][40][41], and autopsy-markers of AD [42] has prompted pFCSRT 1 IR's use in ongoing clinical trials [35,43].…”
Section: Discussionmentioning
confidence: 99%
“…When persons with SMC were classified into subgroups according to their CSF Aβ levels, the Aβ positive group performed lower on several FSCRT scores (i.e., learning, total learning, total recall) than the Aβ negative group. Moreover, both FR and TR were significantly impaired in 88% of prodromal and mild AD patients presenting with memory complaints and who were Aβ+ (Xie et al, 2014). Furthermore, Wagner et al (2012) demonstrated that TR was superior to FR for distinguishing patients with a low CSF Aβ/tau ratio (compatible with AD) from persons with a normal ratio.…”
Section: Introductionmentioning
confidence: 96%